Adamantyl Isothiocyanates as Mutant p53 Rescuing Agents and Their Structure–Activity Relationships
- 7 May 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 64 (10) , 6621-6633
Abstract
Mutant p53 rescue by small molecules is a promising therapeutic strategy. In this structure–activity relationship study, we examined a series of adamantyl isothiocyanates (Ad-ITCs) to discover novel agents as therapeutics by targeting mutant p53. We demonstrated that the alkyl chain connecting adamantane and ITC is a crucial determinant for Ad-ITC inhibitory potency. Ad-ITC 6 with the longest chain between ITC and adamantane displayed the maximum growth inhibition in p53R280K, p53R273H, or p53R306Stop mutant cells. Ad-ITC 6 acted in a mutant p53-dependent manner. It rescued p53R280K and p53R273H mutants, thereby resulting in upregulating canonical wild-type (WT) p53 targets and phosphorylating ATM. Ad-ISeC 14 with selenium showed a significantly enhanced inhibitory potency, without affecting its ability to rescue mutant p53. Ad-ITCs selectively depleted mutant p53, but not the WT, and this activity correlates with their inhibitory potencies. These data suggest that Ad-ITCs may serve as novel promising leads for the p53-targeted drug development.Keywords
Funding Information
- National Cancer Institute (CA100853, P30 CA51008)
- Russian Science Foundation (19-73-10002)
- Russian Fund for Basic Research (20-03-00298)
This publication has 49 references indexed in Scilit:
- The rebel angel: mutant p53 as the driving oncogene in breast cancerCarcinogenesis, 2012
- Mutant p53: one name, many proteinsGenes & Development, 2012
- Allele-Specific p53 Mutant ReactivationCancer Cell, 2012
- Specific Binding of Adamantane Drugs and Direction of Their Polar Amines in the Pore of the Influenza M2 Transmembrane Domain in Lipid Bilayers and Dodecylphosphocholine Micelles Determined by NMR SpectroscopyJournal of the American Chemical Society, 2011
- Selective Depletion of Mutant p53 by Cancer Chemopreventive Isothiocyanates and Their Structure−Activity RelationshipsJournal of Medicinal Chemistry, 2011
- Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayersNature, 2010
- A common gain of function of p53 cancer mutants in inducing genetic instabilityOncogene, 2009
- Synthesis and Anticancer Activity Comparison of Phenylalkyl Isoselenocyanates with Corresponding Naturally Occurring and Synthetic IsothiocyanatesJournal of Medicinal Chemistry, 2008
- Part of the Series: From dietary antioxidants to regulators in cellular signaling and gene regulationFree Radical Research, 2006
- Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compoundNature Medicine, 2002